Intrathecal Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Intrathecal pumps classified under intrathecal drug delivery system are used to deliver small amounts of drug directly to the patient’s spinal fluid for relieving chronic back or spinal pain. This small programmed battery powered pump is surgically implanted under the subcutaneous tissue of the abdomen and is connected to a catheter tunneled to the site of spinal entry. Such devices consist of a computerized pain pump, a catheter and a reservoir which needs to be refilled every 1 to 3 months. In this drug delivery system, a lower dose of medication is required since the drug is delivered directly at the site of action and thus bypasses the phase of circulation throughout the body.

Browse full report at: http://www.transparencymarketresearch.com/intrathecal-pumps-market.html

Intrathecal pumps market is categorized on the basis of the following applications:

• Cancer Pain
• Neuropathic Pain
• Facial & Migraine Pain
• Musculoskeletal Pain
• Trauma

Globally, North America and western European countries dominates the intrathecal implant pumps market due to high prevalence of chronic or recurring pain in the general population, better reimbursement policies and increased awareness about healthcare and wellbeing in these regions. Emerging economies of Asia, Middle East and Latin America are predicted to incur the highest growth due to growing disease awareness and rising affordability in order to undertake such procedures.

Some of the key factors driving the growth of intrathecal pumps market are global growing elderly population and advances in technology. Increased incidences of cancer and diabetes, improved reimbursement policies and funding by government agencies, particularly in developing countries will further propel the intrathecal pumps market. However, high cost involved in implantation procedure of intrathecal pumps may pose a challenge to the growth of this market.

Some of the major companies contributing to the intrathecal pumps market include Baxter International Inc., Boston Scientific Corporation, Codman and Shurtleff, Inc., Hospira, Inc., Kimberly-Clark Corporation, St. Jude Medical, Inc., Medtronic, Inc., Advanced Bionics LLC, Medasys, Inc., Flowonix Medical, Inc., Smiths Medical ASD, Inc. and Stryker Corporation.

More reports on Pharmaceutical market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Global Anti-Migraine Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Antimigraine drugs are the therapeutic agents indicated to use against migraine headaches. Migraine is characterized by recurrent attacks of moderate to severe headaches along with other nervous system symptoms. Migraine is more common in women than men, majorly due to the fluctuations in the harmone levels. According to a Medline article, around 12% of the U.S. population suffers from migraine headaches. The two major types of migraine are classic and common. Classic migraine is characterized by sudden change in eye sight and experience partial blindness or double vision. On the other hand common migraine patients witness sudden headaches on one or both the sides of the head. 

Browse full report at: http://www.transparencymarketresearch.com/anti-migraine-drugs.html

Migraine has a serious social and economic impact; According to National Headache Foundation migraine sufferers experience a loss in more than 157 million work days every year. Migraines cause both personal and professional disturbances and add to the overall healthcare costs to a nation. The treatment of migraine headaches is facilitated by administration of preventive medications, to avoid the migraine attacks and abortive medications to relieve the intense and periodic pain. 

The market for anti-migraine drugs witnesses an upward growth curve majorly due to increasing incidences of migraine sufferers. The market can be segmented by type of therapeutic class of drugs involved in the treatment and geography. The major antimigraine drugs used against migraine includes the drugs belonging to the class, triptans such as Sumatriptan, Zolmitriptan, and others. Major factors influencing the growth of this market is the consistent rise in the incidence rates of migraine cases, increased acceptance levels, increased awareness and technological advances in the development of anti-migraine drugs. 

On the other hand patent expirations, high genericization and emergence of local players may mask the growth of the market. Some of the major market players of this market are Abbott Laboratories, Inc. Eisai, Inc., Eli Lilly and Company, Pfizer, Inc., AstraZeneca plc, and GlaxoSmithKline plc.

More reports on Pharmaceuticals market: 
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Erectile dysfunction (ED) is one of the most common sexual problems of men and the susceptibility to this condition increases with aging. The most likely causes of ED are effects of certain medications (anti-depressants and nicotine), chronic diseases (cardiovascular and diabetes), kidney failure, stressful life style and aging. Poor health, obesity, smoking and poor dietary habits may also cause ED. Hesitation in discussing this condition with physicians has resulted in a large pool of untreated patients. There is no gold standard test to identify ED and is usually diagnosed by going through medical history of the patient, a few physical tests and blood tests. Some blood tests are carried out to exclude underlying causes such as diabetes, high cholesterol level and cardiovascular diseases.

Browse full report at: http://www.transparencymarketresearch.com/erectile-dysfunction-drugs.html

The first line therapy for the treatment of ED is use of phosphodiesterase-5 inhibitors (PDE-5) such as sidenafil, tadalafil and vardenafil. These drugs act by augmenting the effect of nitric oxide that relaxes penile muscles and ensures proper blood flow and allows erection. The use of these drugs is contraindicated when a patient is already taking nitrate drugs, anticoagulants and if he is suffering from cardiovascular diseases and diabetes. Viagra (Pfizer), Cialis (Eli Lilly) and Levitra (Bayer) are the leading brand names in this segment.

The market for erectile dysfunction drugs is growing worldwide due to the rapidly increasing prevalence of ED and is predicted to be doubled by the end of 2025. At present, North America represents the largest market for these drugs due to the existence of large number of population affected with ED and high awareness about healthcare and wellbeing. The Urology Care Foundation, an official foundation of the American Urological Association, estimates that at present an average of 15 to 30 million people are suffering from ED across the country with varying levels of distress. The Massachussetts Male Ageing Study suggests that more than 50% of men aged over 40 years of age experience some degree of ED. 

Asia-Pacific represents a potential market for erectile dysfunction drugs due to growing aging population. One of the other factors expected to drive the market in Asia-Pacific region is increasing awareness about the disease and improvement in healthcare infrastructure.

Some of the prominent players operating in this market space are Pfizer, Inc., Eli Lilly, Bayer Healthcare, Johnson & Johnson, GlaxoSmithKline, Sanofi, Astellas Pharma, Inc. and Merck & Co.

More reports on Pharmaceuticals market: 
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Dyslipidemia Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Dyslipidemia is a lipoprotein metabolism disorder characterized by abnormal amount of lipoprotein (LDL and HDL) concentrations in blood. It is usually caused by genetic factors, secondary factors or a combination of both kinds of factors. High density lipoproteins (HDL) are also known as good cholesterol and higher levels of these help reduce the risk of cardiovascular diseases. Higher levels of low density lipoproteins (LDL) or bad cholesterol are associated with the risk of heart attacks and strokes. 

Browse full report at: http://www.transparencymarketresearch.com/dyslipidemia-market.html

The abnormal levels of cholesterol and triglycerides are capable of producing three forms of dyslipidemia namely, hypertriglyceridemia, hypercholesterolemia and a combination of both. Dyslipidemia is one of the major causes for the occurrence of cardiovascular diseases. Appropriate drug therapy against dyslipidemia can be selected based on the detection of varying concentrations of specific lipoproteins in the blood. The treatment approach adopted by physicians starts with non-drug interventions, which includes lifestyle modifications and exercise followed by pharmacotherapy which includes the use of lipid lowering drugs. 

The seven major classes of lipid lowering drugs used in the treatment of dyslipidemia are bile-acid sequestrants, nicotinic acid, HMG-CoA reductase inhibitors (statins), cholesterol modulators, fibric acid derivatives, cholesterol absorption inhibitors and combination products. Statins are the most widely used drugs to treat dyslipidemia. The dyslipidemia market can be segmented by the various drug classes mentioned above and by geography.  

The major factors influencing the growth of this market are sedentary lifestyle, higher inclination towards junk food, increasing incidence of cardiovascular diseases across the globe and associated risks. Patent expirations and high genericization may mask the growth of this market. With the patent expiration of Pfizer’s Lipitor, Merck’s Zocor and Bristol-Myers Squibb’s Pravachol, the dyslipidemia market is expected to experience a decline in sales of branded formulations and in turn decline in overall growth of this market. Some of the major players in this market are Pfizer, Inc., Merck & Co, Inc., Bristol-Myers Squibb, Novartis AG, AstraZeneca PLC and Abbott Laboratories. 

More reports on Pharmaceuticals market:

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Bioterrorism Detection Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Bioterrorism refers to form of terrorism that involves intentional dissemination or release of biological agents. The agents can be viruses, bacteria or toxins and can also be referred to as germ warfare. Biological agents are mainly found in nature but sometimes they can be modified by the terrorist as to make agents more toxic. Biological agents are used by the terrorists to attain their social or political goals and are used for killing or injuring people, plants and animals. Biological weapons are dangerous as some of these agents are transmitted from one person to another and infection might take hours or days to become noticeable.

Browse full report at: http://www.transparencymarketresearch.com/bioterrorism-detection-market.html

Bioterrorism is an invaluable tool as biological agents are relatively inexpensive and can cause widespread fear beyond the actual damage they can cause. They are mainly used by the terrorists to create mass panic and disruption of state or economy. The global market for bioterrorism is segmented on the type of different biological agents currently being used and their mode of delivery.  Agents such as anthrax, tularemia, small pox, bubonic plague, botulinum toxin and viral hemorrhagic fevers pose a high threat to national security. 

Another category involves toxins such as typhus, glanders, Q fever, viral encephalitis and others poses moderate threat and involves low mortality. Last category involves emerging toxins that are engineered for mass dissemination, high mortality rate and ability to cause major health impact. Hantavirus, Nipah Virus, SARS, HIV/AIDS and H1N1 virus falls under this above mentioned category. The mode of delivery of these biological agents can be via aerosol dissemination, water contamination, food contamination, insect vectors and others.

However, federal government supports many programs and researches but it does not provide any direct protection against bioterrorists attacks for many important buildings. These buildings include theaters, shopping centers, large buildings and others. In the United States virtually all these buildings remain susceptible to bioterrorist attack. Key protection to these facilities involves the presence of warning systems which provide immediate response to such attacks.

Some of the major players that provide and bioterrorism defense products are Acambis Plc, Evogen, Inc., Human Genome Sciences, ICX Technologies, Inc., PharmAthene, Inc. and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

More reports on Pharmaceuticals market: 

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Global Blood Disease Treatment Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Blood comprises of red blood cells, white blood cells, plasma and platelets. Sometimes, people might be affected with different types of blood disorders and blood cancers due to aging, infections, exposure to certain chemicals, smoking, genetic disorders and other factors. Hence, the category of blood disorders is wide and numerous types of diseases fall under it. 

Browse full report at: http://www.transparencymarketresearch.com/blood-disease-treatment-drugs.html

There are three main types of cancer that affect blood namely leukemia which affects the bone marrow and is caused by abnormal production of white blood cells. Myeloma is a type of blood cancer that affects plasma cells whereas lymphoma is a cancer that affects the lymphatic system. The diseases that affect white blood cells are mainly lymphoma and leukemia and  anemia, sickle cell anemia and polycythemia diseases are mainly affecting red blood cells. Diseases such as heparin, thrombocytopenia and essential thrombocytosis affect the platelets found in blood and hemophilia and sepsis affect blood plasma. 

Hematological cancers represent a significant problem globally. Every year more than 100,000 cases of blood cancers are diagnosed in United States and more than 50,000 people die from such cancer cases. Many specific therapies for the treatment of cancers have been developed that include biologics and small-molecule drug therapies. Leukemia accounts for the ninth most common occurring cancer in males across the globe. Leukemia market is segmented into four types that include acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. Thus, with the rise in number of cancer cases the market in future is projected to grow. 

Drugs such as Sprycel, Arranon, Clolar, Gleevec, Quizartinib, Marqibo, and Tasigna are the major drugs available for the treatment of leukemia. The blood diseases treatment drugs market is witnessing competition among the players with drugs in pipeline for early diagnosis and treatment of blood disorders.  

Some of the key players in the blood disease treatment drugs market include Novartis International AG, Celgene Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals, Ambit Bioscience and other major players.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

More reports on Pharmaceutical market:

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Antipsychotic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Antipsychotics are drugs used in the treatment of brain disorders such as schizophrenia, bipolar disorder, and severe depression. According to the New York Times, antipsychotics are one of the largest types of prescribed drugs in the United States with over 3.1 million Americans accounting for a market worth USD 18 billion in 2011 itself. Global estimates suggest that over 1.25% of the global population suffers from psychosis and related disorders. This brings a market of about 7.5 million people suffering from combined disorders of schizophrenia, bipolar disorder, dementia, depression among other rare conditions. 

Browse full report at: http://www.transparencymarketresearch.com/antipsychotic-drugs-market.html

Several recent studies have suggested instances of drug abuse and over prescription of these drugs in the market, particularly in North America. Clinical studies have shown severe drawbacks and addiction to antipsychotic drugs. A serious side effect observed is tardive dyskinesia which is a potentially irreversible movement disorder. These drugs are prescribed for mild symptoms as well, increasing the market for the drugs tremendously.

Antipsychotics market is expected to increase with increasing incidences of Schizophrenia and a very large market of clinical depression. Certain drugs such as Ablify and Seroquel are the topmost in the segment due to their advantage of reduced risk of side-effects. 2012 has observed the end of the several drug patents and it is expected that generic drugs will compete strongly in the market in the coming years. There is an increasing general call in the medical community for adoption of a stronger control while administering these drugs in the coming years. 

Aripiprazole (marketed as Abilify), Asenapine Maleate (marketed as Saphris), Clozapine (marketed as Clozaril), Iloperidone (marketed as Fanapt), Lurasidone (marketed as Latuda), Olanzapine (marketed as Zyprexa), Olanzapine/Fluoxetine (marketed as Symbyax), Paliperidone (marketed as Invega), Quetiapine (marketed as Seroquel), Risperidone (marketed as Risperdal) and Ziprasidone (marketed as Geodon) are the major atypical antipsychotic drugs marketed today. 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

More reports on Pharmaceuticals market: 

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Uranium Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Uranium is mostly used in nuclear power plants to generate electricity. The rising demand for electricity and the capacity of nuclear reactors is driving the uranium market. The global uranium market is expected to witness significant growth in next six years. Nearly 75% of uranium supply is through mining activity and it is expected to grow further in the coming years. 

Browse full report at: http://www.transparencymarketresearch.com/uranium-market.html

Other secondary sources of uranium include civil stockpiles, recycled uranium, and ex-military weapons-grade uranium. It is expected that there will be a balance between the demand and the supply as the number of new reactors being constructed and old plants retiring is nearly the same. 

In the next six years, it is expected that China, Russia, India, the Middle East, and Europe will expand their use of nuclear energy, creating intense competition for mined uranium. China and Russia are the fastest growing markets and they have already started buying huge stakes in uranium mining operations. 

In 2011, after the incident of Fukushima Daiichi reactor owing to Japan’s tsunami and earthquake, the uranium market might witness slow growth. Shortage of uranium may be experienced in the next few years in spite of the abundance of uranium in the earth’s crust, but it takes many years to build and finance uranium mining operations. 

Some of the major factors driving the market are the growing demand for nuclear energy, the economic advantage associated with uranium production, oil price fluctuations, and increased awareness regarding reducing carbon emissions. The restraint faced by the industry is the high entry barrier because it is a highly capital intensive industry and requires a long time to obtain mining permits. Owing to environmental concerns, obtaining a uranium mining permit is a major challenge.  

The global uranium industry is highly concentrated as very few players are operating in relatively few countries. Russia’s Rosatom and Kazakhstan’s Kazatomprom have entered into a joint venture to dominate the uranium market. Some of the key participants in the market are Cameco Corp., African Energy Resources Ltd, Energy Resources of Australia Ltd, American Uranium Corp. Inc., National Atomic Company Kazatomprom, China National Nuclear Corp., Gulf Mines Ltd., and JOGMEC. 

More reports on Pharmaceutical market:

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Browse another blog: http://marketingresearchfirm.wordpress.com

Read More

Multiple Sclerosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Multiple sclerosis (MS) is an inflammation of fatty myelin sheaths around the axons of the brain and spinal cord. MS tends to affect the ability of nerve cells to communicate with each other in the brain and spinal cord. MS affects people with random symptoms based on the location and severity of attack. One event can last for days, weeks or months and can affect any part of the body. Symptoms include imbalance, loss of motor function, spasms, numbness, incontinence, and difficulty in swallowing. 

Browse full report at: http://www.transparencymarketresearch.com/multiple-sclerosis-drugs.html

There is no known cure for the disease currently and the only drugs available in the market are for delaying the progression of the disease. MS is estimated to affect 2.5 million people worldwide with around 5000 new cases developing each year. The National Multiple Sclerosis Society, Multiple Sclerosis Foundation, Multiple Sclerosis Association of America and several others are organizations which are determined to ensure improvement in the lives of affected people to make them more educated and spread awareness of this disease.

Until the last year, the MS drugs market was led primarily by injectables, yet this trend is changing very quickly to give way to oral MS drugs which is expected to grow strongly beginning from 2013. Gilenya and Aubagio are the top current oral drugs in this segment and Biogen’s oral BG-12 and Teva Laquinimod are two other drugs in the pipeline for approval with a significantly higher efficacy to be launched in the next five years. Although oral MS drugs seem to be growing quickly, it is not expected that they would unsettle injectables anytime soon. 

Several fatal side effects have been linked to use of Gilenya among those who have a heart disease and thus shows that there is still a long way to go for oral MS drugs. Top contenders in this segment till now are Copaxone, Avonex, Rebif, Betaseron, and Tysabri. Most of these drugs work actively to control MS relapses. Other treatments such as stem-cell transplantation are currently under investigation. The process includes the injection of stem cells which will replace the affected inflamed and diseased cells, greatly improving patient’s quality of life.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

More reports on Pharmaceutical market: 

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Micro-RNA Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Micro-RNA is a small non-coding RNA molecule which is a vital component of genetic regulation. Set of micro-RNAs are present in plants and animals functioning in gene expression process. They are involved in the normal functioning of the eukaryotic cells. Biogenesis of micro-RNA is the basis for RNA interference drug discovery and research in therapeutics. 

Browse full report at: http://www.transparencymarketresearch.com/micro-rna-market.html

Micro-RNAs are likely to be involved in biological processes by affecting the gene regulation. Research and development of micro-RNA based therapies are recently being exploited due to the implication of unusually expressed micro-RNA in numerous disorders such as cancer, cardiovascular diseases and HIV infections.

The global micro-RNA market if categorized into:

1. Applications

• Research
• Diagnosis
• Therapeutics

2. Technology

• Purification
• Labeling
• Linear amplification
• Microarrays
• qRT-PCR
• Inhibition

Globally, North America and Europe are the leading regions with booming micro-RNA market. Emerging economies of Asia such as India, Japan, China and Singapore as well as the Middle East and Latin American countries are also expected to show soaring progress in the growth of micro-RNA market.

One of the key factors driving the global micro-RNA market is provision of large scale funding by public and private sectors. Other factors responsible for the growth of this market are growing interest of pharmaceutical and biotechnological companies in conducting research on micro-RNAs and identification of micro-RNA role in different disease classes.

Some of the major players contributing to the global micro-RNA market comprises Access Pharmaceuticals, Agilent Technologies, Astrazeneca Pharmaceuticals LP, Benitec Biopharma Limited, Calando Pharmaceuticals, Inc., Covance, Inc., Eli Lilly and Co., F. Hoffman-La Roche AG, Illumina, Inc., Novartis International AG, Senesco Technologies, Inc., Sirnaomics, Inc., Tekmira Pharmaceuticals Corporation and Thermo Fisher Scientific, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

More reports on Pharmaceutical market: 

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Pulmonary Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

The drug delivery method plays a crucial part in the success of any drug. Drugs with high efficacy and those which are easy to use are an instant success in most medical communities and even among patients. Pulmonary drug delivery is the inhalation of aerosol based drugs through a device called “Inhaler” and the drug aerosol is called an inhalable. 

Browse full report at: http://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html

There are several conventional inhalable drugs particularly for chronic conditions such as asthma, chronic obstructive pulmonary diseases (COPD) and congestion. Conventional methods used pulmonary drug delivery only for respiratory diseases. Today other chronic conditions such as diabetes also have inhaled insulin and provide greater patient comfort compared to insulin injections. Pulmonary drug delivery can be both oral and nasal.

The market for pulmonary drug delivery systems is predicted to grow with advancing technology such as automated pulmonary delivery testing systems. Increasing disease applications and innovative designs for devices will account for significant growth of this market. Faster delivery, greater absorbing surface area of tissue, and greater patient comfort are some of the drivers for pulmonary delivery of drugs. Even with these drivers, the market is not without its challenges. 

Research studies show that some people have lower absorption compared to others and thus the dosage has to be adjusted from one person to another making it difficult for physicians to standardize dosage for all people. Different formulations will also be provided a suitable platform for the delivery of other inhaled protein therapeutics besides insulin. Dry powder inhalers (DPIs) are still expected to have technical hurdles till the next few years.

Geographically the market can be focused world-wide and with increasing applications such as insulin, the market is projected to expand rapidly, particularly in Africa and Asia with large percentage of diabetic population. Currently North America and Europe lead the way in  the market respectively, yet the situation is expected to change in another five years. Insulin inhalers were recently approved in Europe and US, and the market is expected to present sizable opportunities in other regions around the world.

More reports on Pharmaceutical market: 
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. 

Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com

Read More

Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market is Expected to Grow to USD 52.3 Billion Globally by 2019

Transparency Market Research published new market report Transparency Market Research published new market report "Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market (Sample Preparation, Electrophoresis, BioChips and Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, Next-Gen Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," in 2012, the global genomics and proteomics reagents, research kits and analytical instruments market was valued at USD 23.8 billion and is expected to grow at a CAGR of 12.1% from 2013 to 2019, to reach an estimated value of USD 52.3 billion in 2019.

Browse the full report at http://www.transparencymarketresearch.com/proteomics-market.html

The global genomics and proteomics market is expected to experience a growth in revenues at a CAGR of 12.1% during the forecast period, mainly due to exponential growth in preclinical and clinical research in drug discovery and disease identification. Since global incidence rates of cancer, diabetes and genetic diseases are on a rise, the market revenue growth is inevitable. Moreover, other emerging applications such as forensics and agriculture are also contributing to the growth which in turn has increased the number of research projects all over the world particularly in genomics. Proteomics has grown with increasing interest in protein mutations due to changes in genome and has given rise to a unique field of proteogenomics which is carving a commercial position for itself.

Genomics and proteomics reached a major milestone after the completion of Human Genome project in 2001. During the process, the research industry realized the need for affordable methods to sequence genomes of other organisms as well. This led to a revolution in life science analytical research tools and technologies such as thermal cyclers, mass spectrometry, and gel electrophoresis. An impressive genome database of various organisms is available today for researchers through various sources such as gene banks. Advancing technology and miniaturization of memory devices in electronics and semiconductors has also played a very significant role in creating this accomplishment. 

Several rare and unknown diseases such as autism, Alzheimer's along with high incidence diseases such as cancer and diabetes are currently being addressed through these technologies by drug discovery, disease identification and structural dynamics of proteins.

A large fragmented market indicates high competitive pricing and no loss in quality of products, thus buyers have multiple options to choose from. Unique software for each application and company specified reagents for machines have reduced the negotiating power of buyers as companies do not guarantee good results without usage of company recommended reagents or software solutions. Customer loyalty is very low as researchers are keen to experiment with different products that may yield better results. A high number of acquisitions and mergers in the field of biotechnology indicate the nature of the market. 

New technological innovations are taking place on a regular basis. Patenting these products and commercializing them is a challenging task for new entrants in the face of giants such as Agilent, Thermo-Scientific, Waters and other players. Thus joint ventures and collaborations with existing players give an excellent platform for new entrants to expand in this field. The threat of new entrants is high and is expected to remain so throughout the forecast period.

Key players leading the genomics and proteomics market are Thermo Fisher Scientific, Agilent Technologies, Life Technologies, Qiagen and Illumina. Intense competition has lowered prices for all types of technologies and is expected to continue further. Miniaturization of technologies such as lab-on-a-chip, biochip and microarray lead the research along with miniaturization of other analytical instruments such as portable mass spectrometers and thermal cyclers.

North America was the largest regional market by revenue in 2012, due to regular break-through innovations in technology that have been introduced in several genomic and proteomic areas. Continued investment in healthcare and medical research is another factor responsible for steady growth in North America. Asia-Pacific and Latin America are expected to show the fastest growth through the forecast period.

The global genomics and proteomics market is segmented into the following categories:

Genomics and Proteomics Market, by Reagent and Research Kits

• Sample Preparation Kits
• Prepackaged Sample Preparation Kits for PCR
• Prepackaged Sample Preparation Kits for Chromatography
• Prepackaged Sample Preparation Kits for Mass Spectrometry
• Prepackaged Sample Preparation Kits for Electrophoresis
• Purification Kits
• Electrophoresis Kits
• Capillary Electrophoresis
• Gel Electrophoresis
• BioChips and Microarrays
• DNA BioChips and Microarrays
• Protein and Peptide BioChips and Microarrays

Genomics and Proteomics Market, by Analytical Instruments

• Chromatography
• Gas Chromatography
• Liquid Chromatography
• Mass Spectrometry, by Analyzers
• Tandem Mass Spectrometry
• Time-Of-Flight Mass Spectrometry
• Quadrupole Mass Spectrometry
• Fourier Transform Mass Spectrometry
• Others (Magnetic Sector, Orbitrap, Ion Trap)

·         Thermal Cyclers

• Digital Thermal Cyclers
• Conventional or Traditional Thermal Cyclers
• Real-Time Thermal Cyclers
• Next Generation Sequencing

Genomics and Proteomics Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Pharmaceutical Market Reports Related Blogs :

http://globalmarketresearch.blogspot.de/

http://medicalcaremarketnews.wordpress.com/

TABLE OF CONTENTS (TOC Summary)

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Global Genomics and Proteomics Market Overview

Chapter 4 Global Genomics and Proteomics Reagents and Research Kits Market

Chapter 5 Global Genomics and Proteomics Analytical Tools Market, by Technologies, 2011 - 2019 (USD Million)

Chapter 6 Genomics and Proteomics Market, by Geography, 2011 - 2019 (USD Million

Chapter 7 Market Share Analysis of Key Players, 2012

Chapter 8 Company Profiles

Browse Related reports With Full TOC at

http://www.transparencymarketresearch.com/molecular-diagnostics-market.html

http://www.transparencymarketresearch.com/forensics-technology.html

http://www.transparencymarketresearch.com/pain-management-therapeutics.html

About Us:

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Browse the report With Full TOC at http://www.transparencymarketresearch.com/proteomics-market.html

Read More